Capitolis Advisors LLC Edwards Lifesciences Corp Transaction History

Capitolis Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $3.7 Million - $4.65 Million	-36,245 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $1.23 Million - $1.51 Million	11,530 Added 46.65%	36,245 $4.7 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $1.34 Million - $1.6 Million	13,018 Added 111.29%	24,715 $2.75 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $2.06 Million - $2.57 Million	-24,526 Reduced 67.71%	11,697 $1.21 Million
Q4 2020 May 07, 2021	BUY	$71.69 - $91.23 $2.6 Million - $3.3 Million	36,223 New	36,223 $3.31 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.